Alternate site gene therapy

Details Alternate site gene therapy Alternate site gene therapy

2006-11-28

2006-11-28

Williams, Catherine S. (Department: 3763)

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

C604S021000

Reexamination Certificate

active

07141044

ABSTRACT:
A method is described for performing gene therapy at an alternate site when it is undesirable or impossible to perform gene therapy at the injured or diseased region. A gene therapy composition is administered using a catheter adapted to deliver ultrasound to facilitate uptake of the gene therapy composition into one or more cells at the alternate site. The treated section may then be transplanted to another region of the body which is diseased or injured.

REFERENCES:
patent: 4821740 (1989-04-01), Tachibana et al.
patent: 4953565 (1990-09-01), Tachibana et al.
patent: 5007438 (1991-04-01), Tachibana et al.
patent: 5081993 (1992-01-01), Kitney
patent: 5158071 (1992-10-01), Umemura et al.
patent: 5197946 (1993-03-01), Tachibana
patent: 5269291 (1993-12-01), Carter
patent: 5318014 (1994-06-01), Carter
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5362309 (1994-11-01), Carter
patent: 5368036 (1994-11-01), Tanaka et al.
patent: 5380273 (1995-01-01), Dubrul et al.
patent: 5415636 (1995-05-01), Forman
patent: 5431663 (1995-07-01), Carter
patent: 5474531 (1995-12-01), Carter
patent: 5558642 (1996-09-01), Schweich et al.
patent: 5569198 (1996-10-01), Racchini
patent: 5609574 (1997-03-01), Kaplan et al.
patent: 5628728 (1997-05-01), Tachibana et al.
patent: 5630837 (1997-05-01), Crowley
patent: 5713848 (1998-02-01), Durbrul et al.
patent: 5735811 (1998-04-01), Brisken
patent: 5779673 (1998-07-01), Roth et al.
patent: 5836896 (1998-11-01), Rosenschein
patent: 5846218 (1998-12-01), Brisken et al.
patent: 5876989 (1999-03-01), Berg et al.
patent: 5895356 (1999-04-01), Andrus
patent: 5916192 (1999-06-01), Nita et al.
patent: 5922687 (1999-07-01), Mann et al.
patent: 5938595 (1999-08-01), Glass et al.
patent: 5941868 (1999-08-01), Kaplan et al.
patent: 5997497 (1999-12-01), Nita et al.
patent: 6001069 (1999-12-01), Tachibana et al.
patent: 6024718 (2000-02-01), Chen et al.
patent: 6096000 (2000-08-01), Tachibana et al.
patent: RE36939 (2000-10-01), Tachibana et al.
patent: 6135976 (2000-10-01), Tachibana et al.
patent: 6176842 (2001-01-01), Tachibana et al.
patent: 6210356 (2001-04-01), Anderson et al.
patent: 6228046 (2001-05-01), Briskin
patent: 6287271 (2001-09-01), Dubrul et al.
patent: 6296619 (2001-10-01), Brisken et al.
patent: 6346098 (2002-02-01), Yock et al.
patent: 6372498 (2002-04-01), Newman et al.
patent: 6425853 (2002-07-01), Edwards
patent: 6461296 (2002-10-01), Desai
patent: 6652581 (2003-11-01), Ding
patent: 6680301 (2004-01-01), Berg et al.
patent: 6794369 (2004-09-01), Newman et al.
patent: 6929633 (2005-08-01), Evans et al.
patent: 2002/0032394 (2002-03-01), Brisken et al.
patent: 2002/0068717 (2002-06-01), Borreiil
patent: 2003/0069525 (2003-04-01), Brisken et al.
patent: 2004/0039329 (2004-02-01), Ueberle
patent: 2004/0106841 (2004-06-01), Shaw et al.
patent: 2005/0027247 (2005-02-01), Carrison et al.
patent: H02-180275 (1990-07-01), None
patent: WO 96/07432 (1996-03-01), None
patent: WO 97/19645 (1997-08-01), None
patent: WO 99/25385 (1999-05-01), None
patent: WO 99/33500 (1999-07-01), None
patent: WO 99/34858 (1999-07-01), None
patent: WO 99/39738 (1999-08-01), None
Akhtar,Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?(J. Antimicrob Chemother. 38(2): 159-165, 1996).
Anderson,Human gene therapy. (Nature 392:25-30, 1998).
Branch,A Good Antisense Molecule is Hard to Find, (Trends in Biochem Sci 23: 45-50, 1998).
Crooke,Basic Principles of Antisense Therapeutics(Springer-Verlag, Eds, New York, 1998, pp. 1 and 4).
Ho and Parkinson,Antisense Oligonucleotides as Therapeutics for Malignant Diseases, (Seminars in Drug Discovery 24(2): 187-202, 1997).
Orkin and Motulsky,Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, (p. 1-38, Dec. 7, 1995).
Romano et al.,Latest Developments in Gene Transfer Technology: Achievements, Perspectives, and Controversies over Therapeutic Applications, (Stem Cells 18: 19-39, 2000).
Somia and Verma,Gene Therapy: Trials and Tribulations, (Nature Reviews Genetics 1: 91-99, 2000).
Verma et al.,Gene Therapy—promises, problems and prospects, (Nature 389: 239-242, 1997).

Affiliated with

Also associated with

Rating

Alternate site gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Alternate site gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alternate site gene therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3660128